NOTE: It’s easy! Submit your order and Pet’s First Choice will verify your pet’s prescription with your veterinarian. Please allow 24-48 hours for this validation.
Varenzin™-CA1 for Cats Oral Suspension 27ml
$79.99
Description
Varenzin™-CA1 (molidustat oral suspension) is the first FDA-approved treatment specifically for the management of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. This prescription medication helps the body stimulate natural erythropoietin production, supporting healthy red blood cell levels and improving oxygen delivery throughout the body.
Designed for cats with CKD who develop anemia, Varenzin-CA1 provides a targeted, once-daily oral treatment that improves quality of life by increasing energy, appetite, and overall vitality. It’s administered by the pet parent at home and prescribed by your veterinarian as part of a long-term kidney care plan.
-
FDA-Approved for Cats – First and only approved drug for anemia caused by CKD in cats.
-
Stimulates Red Blood Cell Production – Encourages natural erythropoietin to reduce anemia.
-
Improves Energy & Appetite – Helps restore vitality in cats suffering from fatigue or lethargy.
-
Easy Oral Dosing – Once-daily liquid suspension for convenient at-home administration.
-
Supports Long-Term Kidney Care – Addresses a common complication of feline kidney disease.
-
Veterinarian-Prescribed – Should be used as part of a comprehensive CKD treatment plan.
-
Well-Tolerated – Designed specifically for feline physiology with safety in mind.
